Tesla, Amazon, Netflix and NIO
For Immediate ReleaseChicago, IL – December 4, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog....
Could Gene Therapy Cure Sickle Cell Disease? Two New Studies Raise Hopes – Consumer Health News
SATURDAY, Dec. 5, 2020 (HealthDay News) -- A pair of new gene therapies promise a potentially lasting cure for sickle...
No more lip service: ethical fashion and ‘the true cost of clothes’ | Business
Fashion brands have been told they must do more than just make “commitments” to ethical practices, with experts saying that...
Facing the political realities of school funding
When the state Commission to Study School Funding delivered its 180-page final report to Gov. Chris Sununu and the state...
Janssen Presents First Data from the Phase 1 Study of the GPRC5DxCD3 Bispecific Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
RARITAN, N.J., Dec. 5, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial data for the...
Exploring Perceived Stress among Students in Turkey during the COVID-19 Pandemic
This article was originally published here Int J Environ Res Public Health. 2020 Dec 2;17(23):E8961. doi: 10.3390/ijerph17238961. ABSTRACT Students have...
ProAssurance (PRA) Up 7.4% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for ProAssurance (PRA). Shares have added about 7.4% in...
Motor Spindle for Consumer Electronic Market to Witness Robust Expansion by 2027
Motor Spindle for Consumer Electronic Market research report is the new statistical data source added by A2Z Market Research. “Motor Spindle for...
Roche announces new data reinforcing the long-term benefit of Venclexta/Venclyxto-based combination for people with relapsed or refractory chronic lymphocytic leukaemia
Long-term follow-up data from the phase III MURANO trial showed sustained progression-free survival with fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan MURANO and...
Apple Co-Founder Wozniak’s New Venture Lists Token to Help Fund Energy Efficiency Projects
Apple co-founder Steve Wozniak has launched Efforce, a company that facilitates investments in energy efficiency projects via cryptocurrency and blockchain...
